SCHEMBL6189191

SCHEMBL6189191

O=C(O)c1cnc2cc3c(cc2n1)OCO3

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
HPGD P15428 2/20 0.50
ALOX15 P16050 1/20 0.50
HSD17B10 Q99714 1/20 0.50
MAPK1 P28482 1/20 0.42
CTNNB1 P35222 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.39
TP53 P04637 2/20 0.39
CYP1A2 P05177 1/20 0.39
HIF1A Q16665 1/20 0.39
PDGFRB P09619 1/20 0.39
PDGFRA P16234 1/20 0.39
IGFBP3 P17936 2/20 0.39
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
SRD5A2 P31213 1/20 0.38
DHODH Q02127 1/20 0.38
LMNA P02545 4/20 0.37
HTT P42858 4/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1650792 0.78 ALDH1A1 (0.43) ALDH1A1HPGDHSD17B10MAPK1CTNNB1
SCHEMBL9318696 0.77 ALOX15 (0.58) ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2
SCHEMBL5553780 0.77 MGAM (0.51) ALDH1A1HPGDMAPK1CTNNB1SMN1; SMN2
Hydrogen Sulfide SCHEMBL28775857 0.75 MGAM (0.50) ALDH1A1HPGDMAPK1CTNNB1SMN1; SMN2
SCHEMBL6386860 0.75 ALDH1A1 (0.56) ALDH1A1HPGDALOX15HSD17B10MAPK1
SCHEMBL6386976 0.75 ALOX15 (0.56) ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2
SCHEMBL6389963 0.75 ALDH1A1 (0.47) ALDH1A1MAPK1SMN1; SMN2TP53CYP1A2
SCHEMBL6386677 0.75 ALOX15 (0.56) ALDH1A1HPGDALOX15HSD17B10SMN1; SMN2
SCHEMBL6083926 0.73 NPC1 (0.56) ALDH1A1HPGDHSD17B10MAPK1SMN1; SMN2
SCHEMBL7255877 0.73 NPC1 (0.56) ALDH1A1HPGDHSD17B10MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1595871-A2 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases NPS PHARMACEUTICALS, INC. (US) 2005-11-16 EP disclosed
EP-1196397-B1 METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS AND THEIR USE FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES NPS PHARMA INC (US) 2005-08-17 EP disclosed
EP-1196397-A1 METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS AND THEIR USE FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES NPS PHARMACEUTICALS, INC. (US) 2002-04-17 EP disclosed
WO-2000073283-A1 METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS AND THEIR USE FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES NPS PHARMACEUTICALS, INC. (US) 2000-12-07 WO disclosed